Lukasz Przybyl

Poznan, WP 61704, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study.

Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study.

Journal: International journal of molecular sciences

Published: June 02, 2026

4-N-furfurylcytosine, a novel cytosine-derived modulator of mitochondrial and redox homeostasis to counteract aging: Insights from cellular and mouse models.

4-N-furfurylcytosine, a novel cytosine-derived modulator of mitochondrial and redox homeostasis to counteract aging: Insights from cellular and mouse models.

Journal: Free radical biology & medicine

Published: March 20, 2026

CAG-targeting artificial miRNA with reduced off-target risk for efficient lowering of pathogenic polyglutamine proteins.

CAG-targeting artificial miRNA with reduced off-target risk for efficient lowering of pathogenic polyglutamine proteins.

Journal: NAR molecular medicine

Published: January 08, 2026

Challenges in visualizing endogenous loci in the human genome using CRISPR-based imaging systems.

Challenges in visualizing endogenous loci in the human genome using CRISPR-based imaging systems.

Journal: Biotechnologia

Published: December 16, 2025

Impact of dietary salicylates on angiogenic factors and biochemical parameters in a rat model of preeclampsia.

Impact of dietary salicylates on angiogenic factors and biochemical parameters in a rat model of preeclampsia.

Journal: PloS one

Published: May 14, 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis.

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis.

Journal: Frontiers in pharmacology

Published: July 26, 2024

CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models.

CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models.

Journal: Molecular therapy. Nucleic acids

Published: July 19, 2024

What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?

What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?

Journal: International journal of molecular sciences

Published: January 28, 2023

A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease.

A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease.

Journal: Molecular therapy. Nucleic acids

Published: September 11, 2021

What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.

What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.

Journal: International journal of molecular sciences

Published: January 05, 2021

COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.

COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.

Journal: BMC cancer

Published: May 27, 2020

Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy.

Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy.

Journal: American journal of reproductive immunology (New York, N.Y. : 1989)

Published: March 28, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026